Want to contact an Unithroid attorney in District of Columbia?...Get a free case evaluation from one of our Unithroid attorneys in District of Columbia now.
Unithroid - News Articles
-
Jun 8, 2007
CNW Telbec (Communiqués de presse), Canada -
The decrease reflects a significant decline in Rx revenues in Caguas, Puerto Rico as a result of volume declines for Zocor(R) and Levothyroxine sodium. ... -
May 30, 2007
Daily Press, VA -
Synthroid, Levoxyl, Levothroid and Unithroid all contain levothyroxine or T4. But thyroid glands actually make T3 as well as T4, and Armour contains both. You can learn more about this issue as well as interpreting thyroid tests and symptoms of thyroid problems in our ... -
May 17, 2007
Hartford Courant, CT -
Synthroid, Levoxyl, Levothroid and Unithroid all contain levothyroxine or T4. But thyroid glands actually make T3 as well as T4, and Armour contains both. Write Joe and Teresa Graedon in care of The Hartford Courant, 285 Broad St., Hartford, CT 06115, or e-mail them ... -
May 21, 2007
Jackson Clarion Ledger, MS -
By Joe and Teresa Graedon. Q: My 5-year-old granddaughter sucks her thumb. Is there something that tastes bitter or unpleasant I can buy to put on her thumb to remind her to not suck it?A: Most children give up on thumb sucking before they are 5. The ... -
May 22, 2007
The Spokesman Review, WA -
Q. My 5-year-old granddaughter sucks her thumb. Is there something that tastes bitter or unpleasant I can buy to put on her thumb to remind her to not suck ... -
May 10, 2007
PharmaLive.com (press release), PA -
LEVOXYL(R) (levothyroxine sodium tablets, USP) net sales decreased to $22 million during the first quarter ended March 31, 2007 from $31 million during the first quarter of 2006. King's Meridian Medical Technologies business contributed revenue totaling $43 million during the first quarter of ... -
May 10, 2007
Genetic Engineering News (press release), NY -
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced financial results for the first quarter of 2007 and provided additional information ... -
May 11, 2007
PharmaLive.com (press release), PA -
SAN DIEGO--(BUSINESS WIRE)--May 10, 2007 - Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced financial results for the first quarter of 2007 was $291.2 million, or $2.89 per share, compared with loss from discontinued operations of $128.5 million, or $1.66 per ... -
May 11, 2007
Hemscott, UK -
SAN DIEGO (AP) - Ligand Pharmaceuticals Inc. said Friday it swung to a profit in the first quarter on the sale of its pain drug Avinza to King Pharmaceuticals Inc.The company earned $274.3 million, or $2.72 per share, compared with a loss of $142.2 million, or $1.84 ... -
Feb 16, 2007
PharmaLive.com (press release), PA -
as well as a list of currently marketed drug product that your firm provide to FDA, you market calcium chloride, levothyroxine sodium, and vasopressin. These injectable products are drugs within the meaning of Section 201(g) of the Federal Food, Drug and Cosmetic Act ...
-
Feb 15, 2007
Reuters -
Abraxis also has been marketing three injectable drugs -- calcium chloride, levothyroxine sodium and vasopressin -- without having FDA-approved applications , the letter said. Company spokeswoman Christine Cassiano said Abraxis wasworking with the FDA to resolve the manufacturing issues. "We ... -
Feb 20, 2007
Pharma Times (subscription), UK -
The letter also notes that Abraxis also has been marketing three injectable drugs - calcium chloride, levothyroxine sodium and vasopressin - without having ... -
Feb 6, 2007
WISC, WI -
"There are a number of preparations out there, there's synthroid, unithroid, levythryoid. There all the same medication essentially. They're just made by different manufacturers. They're all levothyroxine, which is synthetic thyroid hormone," Bekx said.But experts said that ... -
Jan 4, 2007
Bizjournals.com, NC -
Mylan Laboratories Inc. has received US Food and Drug Administration approval to market Levothyroxine sodium tablets, a generic form of Levothroid tablets, used to treat deficiency of thyroid activity. Total U.S. sales for all strengths of Levothroid tablets were about ... -
Jan 3, 2007
Bolsamania.com, Spain -
(PRN) - Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R) [+]. (PRN) - Carnival Corporation & plc Signs Letter of ... -
Jan 4, 2007
Phoenix Business Journal, AZ -
Mylan Laboratories Inc. has received US Food and Drug Administration approval to market Levothyroxine sodium tablets, a generic form of Levothroid tablets, used to treat deficiency of thyroid activity. Total U.S. sales for all strengths of Levothroid tablets were about ... -
Jan 3, 2007
MSN Money -
Mylan Lab's Levothyroxine sodium tablets USP approved as generic equivalent to Levothroid Co announces that the FDA has granted the co approval to market its currently approved Levothyroxine Sodium Tablets, USP as a bioequivalent and, therefore, therapeutically equivalent product to Levothroid Tablets (manufactured ... -
Sunday, January 07, 2007
Bolsamania.com, Spain -
(PRN) - Carnival Corporation & plc Signs Letter of Intent for New 116000-ton Ship for P&O Cruises [+]. (PRN) - NACCO Industries, Inc. Increases Tender ... -
Jan 3, 2007
StreetInsider.com (subscription), MI -
announced that the US Food and Drug Administration (FDA) has granted the company approval to market its currently approved Levothyroxine Sodium Tablets, USP as a bioequivalent and, therefore, therapeutically equivalent product to Levothroid Tablets (manufactured by Lloyd Pharmaceuticals for Forest Laboratories ... -
Jan 3, 2007
Reuters -
N: Quote, Profile , Research), a maker of generic drugs, said it received US Food and Drug Administration approval to market Levothyroxine sodium tablets as ...
Want to contact an Unithroid attorney in District of Columbia?...Get a free case evaluation from one of our Unithroid attorneys in District of Columbia now.
